Navigation Links
Mass. Eye and Ear, Joslin Diabetes announce collaboration in eye care
Date:9/10/2012

Massachusetts Eye and Ear and the Joslin Diabetes Center announced today that they have reached agreement to form a clinical and research alliance, aimed toward providing coordinated high quality care to eye patients throughout greater Boston, especially those with or at-risk for diabetes-related eye disease.

The new collaboration brings together Boston's two most advanced clinical eye departments, Joslin's Beetham Eye Institute (BEI) and Mass. Eye and Ear's Department of Ophthalmology. The alliance will provide an expanded Longwood Ophthalmology Service for present and future patients. The combined center will be co-located at the Joslin Diabetes Center at 1 Joslin Place and Mass. Eye and Ear's new ambulatory care center at 800 Huntington Avenue.

"Mass. Eye and Ear and Joslin's Beetham Eye Institute have had a long-time collaboration as part of Harvard Medical School's Department of Ophthalmology," said Joan W. Miller, Chief of Ophthalmology at Mass. Eye and Ear and Chair of Ophthalmology at Harvard Medical School. "Combining the expertise and resources of these clinical and academic giants will strengthen this collaboration and advance our shared goal of eradicating eye disease.

The collaboration will operate under the direction of BEI's medical director Dr. Lloyd Paul Aiello. Dr. Aiello is a vice-chair in the Harvard Department of Ophthalmology, as well as an accomplished clinician-scientist and a leader in the HMS angiogenesis research group. This group first identified vascular endothelial growth factor (VEGF) as a key regulator of abnormal new blood vessels in eye disease. Dr. Aiello is also the founding chairperson of the Diabetic Retinopathy Clinical Research Network and he already leads Mass. Eye and Ear's ophthalmology service at Brigham and Women's Hospital.

"It is an honor to lead such a talented group of physicians," said Dr. Aiello. "This enhanced collaboration between our two world-class institutions will provide an outstanding level of clinical care based on extensive experience and cutting-edge research for all patients with eye disease."

The Beetham Eye Institute has long led the way in both clinical care and research for patients with or at-risk of developing diabetic-related eye disease. This agreement assures that BEI will remain a vital center for providing coordinated, integrated and comprehensive care in preventing, diagnosing and treating eye problems related to diabetes.

Mass. Eye and Ear's areas of specialization include: cataract surgery, glaucoma, macular degeneration, corneal disease, oculo plastics, neuro-ophthalmology, vision rehabilitation, immunology/uveitis, genetics, eye tumors including choroidal melanoma and retinoblastoma, and laser vision correction.


'/>"/>

Contact: Mary Leach
Mary_Leach@meei.harvard.edu
617-573-4170
Massachusetts Eye and Ear Infirmary
Source:Eurekalert

Related medicine news :

1. Mass. Eye and Ear Researcher receives RPB Award
2. Mass. Eye and Ear and HMS department of ophthalmology receives RPB Grant
3. Joslin scientists identify important mechanism that affects the aging process
4. Mobile apps for diabetes present usability issues for older adults
5. In Diabetes, Any Protein in Urine May Signal Heart Risk
6. Mayo Clinic: Diabetes can be controlled in patients after pancreas removal
7. Confusion Over Diabetes Types Adds to Patients Woes
8. Psoriasis patients at high risk of diabetes
9. Radiation for Childhood Cancer Might Raise Diabetes Risk
10. Circadian clock research may enable designer plants, and cancer and diabetes treatments
11. Sensor detects glucose in saliva and tears for diabetes testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... ... The American Cleft Palate-Craniofacial Association (ACPA) is pleased to announce KLS Martin ... supporter of the event. , "We are pleased that KLS Martin is joining us ... ACPA President. "KLS Martin has a long track record of support of the American ...
(Date:2/23/2017)... ... ... Hamlin Dental Group and Dr. Hamid Reza, dentist in North Hollywood ... of February, patients who visit Hamlin Dental Group will receive a ticket for a ... the Cheesecake Factory. , Tickets are available for routine dental visits and other ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... provider for the National Institute for Health and Care Excellence (NICE) ... in the National Health Service (NHS) to search, order and purchase medical and ...
(Date:2/23/2017)... ... February 23, 2017 , ... Dr. David Mahon leads Siena ... 89052. Dr. Mahon was named a 2017 Top Patient Rated Henderson Dentist ... online directory that recognizes local physicians and dentists who have earned high ratings and ...
(Date:2/23/2017)... ... 2017 , ... ERT, a global data and technology company ... a leading clinical development service provider, has selected ERT’s Trial Oversight suite as ... part to an array of circumstances including the use of multiple data capture ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Md. , Feb. 23, 2017 ... marketing of the PhenoTest BC Kit, performed on ... to identify organisms that cause bloodstream infections and ... likely to respond to (antibiotic sensitivity). The test ... to provide this important information, which can guide ...
(Date:2/24/2017)... MELBOURNE , Australien, 24. Februar 2017 /PRNewswire/ ... innovatives, diversifiziertes Unternehmen des Gesundheitsbereiches, ist erfreut, für ... Vergleich mit dem entsprechenden Vorjahreszeitraum exzellente Ergebnisse vorlegen ... BioMedical und Aktualisierung zum Wachstum" finden Sie ... Gewinn nach Steuern 2,12 Millionen USD (Dez. 2015: ...
(Date:2/24/2017)... , Feb. 23, 2017  Directors from Pharma To Market ... companies have joined forces, resulting in the founding of Pharma To ... Pharma To Market are pleased to announce their expansion into ... in Singapore . The company are delighted to ... Co-Director of the Singapore based entity. Joelle ...
Breaking Medicine Technology: